The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2010
The objective of this study is to evaluate the effect of ginkgo biloba (steady state) on the pharmacokinetics of a single dose of the UGT-substrate raltegravir. Furthermore the safety profile of the combination is studied.
Epistemonikos ID: 8f08ce62a3257880d5823b5265b95013661064cf
First added on: Dec 01, 2021